Ping Zhang, PhD; Michael M. Engelgau, MD; Susan L. Norris, MD; Edward W. Gregg, PhD; K. M. Venkat Narayan, MD
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Ping Zhang, PhD, Division of Diabetes Translation, Centers for Disease Control and Prevention, Mailstop K-10, 4770 Buford Highway NE, Atlanta, GA 30341; e-mail, email@example.com.
Current Author Addresses: Drs. Zhang, Engelgau, Norris, Gregg, and Narayan: Division of Diabetes Translation, Centers for Disease Control and Prevention, Mailstop K-10, 4770 Buford Highway NE, Atlanta, GA 30341
Facing limited resources and increases in demand from competing programs, policymakers and health care providers seek guidance from economic studies on how to use health care resources wisely. Previous economic studies mainly focused on estimating the cost of diabetes and cost-effectiveness of different interventions. These studies found that diabetes is costly and that its cost will continue to increase; thus, more resources should be devoted to research aimed at finding effective means to prevent the disease and its complications. In addition, the cost-effectiveness of interventions varies greatly in terms of quality-adjusted life-years gained; therefore, efficient uses of resources should be an important consideration when interventions are prioritized. The need for economic studies will continue to grow because of increasing demand for limited resources from the growing number of interventions available. Future studies should be of better quality and broadened in areas of research.
Table 1. Total Economic Cost of Diabetes in the United States in 2002*
Table 2. Three Economic Methods of Evaluating an Intervention in Health and Medicine
Table 3. Cost–Utility or Cost–Benefit Ratio of Interventions To Prevent and Treat Diabetes from the Perspective of the Single Payer
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Zhang P, Engelgau MM, Norris SL, Gregg EW, Venkat Narayan KM. Application of Economic Analysis to Diabetes and Diabetes Care. Ann Intern Med. 2004;140:972–977. doi: 10.7326/0003-4819-140-11-200406010-00039
Download citation file:
Published: Ann Intern Med. 2004;140(11):972-977.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only